XML 90 R81.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Deficit - Co-Founder Grants (Details) - Restricted Stock
shares in Millions, $ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 31, 2017
tranche
shares
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2021
shares
Sep. 30, 2023
USD ($)
shares
Sep. 30, 2022
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares granted (in shares)         20.4  
Vesting period         4 years  
Awards vesting (in shares)         0.0  
Co-Founder Grant            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Expiration period 10 years          
Number of tranches | tranche 9          
Trading period 30 days          
Allocated share-based compensation expense | $   $ 1.5 $ 2.6   $ 5.7 $ 9.5
Remaining unamortized stock-based compensation | $   $ 3.7     $ 3.7  
Co-Founder Grant | Tranche One            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting period 4 years          
Co-Founder Grant | Tranche One | Maximum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Percentage vested maximum 20.00%          
Co-Founder Grant | Chief Executive Officer            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares granted (in shares) 10.3          
Awards vesting (in shares)       2.1